Siobhan Miick

Siobhan Miick, Ph.D., currently serves as the Director of Translational Science at Caris Life Sciences, a position held since July 2022. Prior to this role, Siobhan held various positions at Invivoscribe, including Senior Development Manager and Development Manager from January 2020 to July 2022. Siobhan's extensive experience at Hologic Gen-Probe from 2003 to 2018 included roles as Principal Scientist and Associate Director, focusing on assay feasibility and leading teams in the development of multiplex amplification technologies. Earlier in Siobhan's career, work as Program Leader/Senior Scientist at Nanogen, Inc. involved leading assay development for electronic micro-array platforms. Siobhan earned a Ph.D. in Biophysical Chemistry from the University of California, Santa Cruz, and completed a postdoctoral fellowship at Scripps Research, along with a BS in Chemistry from the University of California, Berkeley.